Investing.com - Merck reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.24 on revenue of €4.87B. Analysts polled by Investing.com anticipated EPS of €2.05 on revenue of €4.73B.
Merck shares are down 13% from the beginning of the year, still down 0.17% from its 52 week high of €188.50 set on August 5. They are under-performing the STOXX 600 which is up 17.76% from the start of the year.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Siemens Healthineers on July 29, who reported EPS of €0.56 on revenue of €5B, compared to forecasts EPS of €0.4864 on revenue of €4.49B.
Bayer had beat expectations on Thursday with second quarter EPS of €1.61 on revenue of €10.85B, compared to forecast for EPS of €1.54 on revenue of €10.15B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar